MedTech in 2019: M&A to continue, robotics & cardiovascular tech drive growth
Although medical device companies continue to be careful with their budgets, they are still on watch and are making room for strategic acquisitions that will bring a big boost to their portfolios. In a brief interview with MedTech Intelligence, Karl Freimuth, partner and co-head of the U.S. industrials practice at Livingstone, an independent M&A and advisory firm, expands on his latest report, “2018 Year in Review & 2019 Outlook” and what he sees as key industry drivers, challenges and opportunities.
Read the full article on the Medtech Intelligence site.
- BlogA strong outlook for medtech in 2019Karl Freimuth analyzed 30+ medtech acquisitions completed in 2018 and looks forward to what 2019 has in store for the sector.
- BlogExamining the medtech M&A boomLivingstone polled four industry experts to explore the key factors driving the medtech M&A boom.
- NewsLivingstone finances transformative medtech acquisitionLivingstone is pleased to announce it has raised financing for Vander-Bend Manufacturing, Inc. (“Vander-Bend” or the “Company”), a portfolio company of Aterian Investment Partners (“Aterian” or the “Sponsor”), in support of its acquisition of J.L. Haley Enterprises Inc. (“Haley”). Cerberus Capital...
- Livingstone’s precision yields strategic buyer for medtech pioneerLivingstone’s Industrial team is pleased to announce the sale of LaVezzi Precision Inc. (“LaVezzi” or the “Company”) to MW Industries, Inc. (“MWI”), a portfolio company of American Securities. Livingstone acted as exclusive financial advisor to LaVezzi. Terms were not disclosed. A third generation...